Formula for calculating the EUTOS risk score (spleen measured in cm below the costal margin, basophils in %) and the EUTOS risk calculated for patients with CCgR-status at 18 months for whom data on spleen size and basophils were available
Risk . | No CCgR at 18 mo (15-21 mo) . | CCgR at 18 mo (15-21 mo) . | n (%) . | ||
---|---|---|---|---|---|
Learning sample | |||||
Low risk | 118 | 14% | 718 (92% of 778) | 86% | 836 (90) |
High risk | 30 (20% of 148) | 33% | 60 | 67% | 90 (10) |
n % | 148 | 16% | 778 | 84% | 926 |
Validation sample | |||||
Low risk | 33 | 14% | 209 (92% of 228) | 86% | 242 (89) |
High risk | 10 (23% of 43) | 34% | 19 | 66% | 29 (11) |
n % | 43 | 16% | 228 | 84% | 271 |
Total | |||||
Low risk | 151 | 14% | 927 (92% of 1006) | 86% | 1078 (90) |
High risk | 40 (21% of 191) | 34% | 79 | 66% | 119 (10) |
n % | 191 | 16% | 1006 | 84% | 1197 |
Risk . | No CCgR at 18 mo (15-21 mo) . | CCgR at 18 mo (15-21 mo) . | n (%) . | ||
---|---|---|---|---|---|
Learning sample | |||||
Low risk | 118 | 14% | 718 (92% of 778) | 86% | 836 (90) |
High risk | 30 (20% of 148) | 33% | 60 | 67% | 90 (10) |
n % | 148 | 16% | 778 | 84% | 926 |
Validation sample | |||||
Low risk | 33 | 14% | 209 (92% of 228) | 86% | 242 (89) |
High risk | 10 (23% of 43) | 34% | 19 | 66% | 29 (11) |
n % | 43 | 16% | 228 | 84% | 271 |
Total | |||||
Low risk | 151 | 14% | 927 (92% of 1006) | 86% | 1078 (90) |
High risk | 40 (21% of 191) | 34% | 79 | 66% | 119 (10) |
n % | 191 | 16% | 1006 | 84% | 1197 |